Senju Pharmaceutical Co.

Closed portfolio with an early-phase archive tilt

According to ClinicalTrials.gov-derived indexes, Senju Pharmaceutical Co. sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).

5 total trials none currently recruiting 4 completed early-phase tilt upper quartile by trial count

Senju Pharmaceutical Co.: 5 sponsored US clinical trials, none currently recruiting.

Senju Pharmaceutical Co. sponsors 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 4 completed. 1 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Dry Eye Syndrome, with 1 trials.

Upper-quartile sponsor footprint

Senju Pharmaceutical Co. sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Indexed trials (enrollment closed)

5 total, page 1 of 1

COMPLETED Phase 1

Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease

NCT04139122
TERMINATED Phase 2

A Study to Assess the Safety, Tolerability and Effectiveness of MT-0814 for the Treatment of Age-related Macular Degeneration

NCT03869684
COMPLETED Phase 3

A Study to Assess the Safety and Effectiveness of SJP-0035 for the Treatment of Patients With Dry Eye Disease

NCT03527212
COMPLETED Phase 2

Safety and Efficacy of SJP-0035 Ophthalmic Solution in Patients With Moderate to Severe Corneal Epithelial Disorders

NCT02929823
COMPLETED Phase 2

Safety and Efficacy Study of SJP-0035 Ophthalmic Solution in Patients With Moderate to Severe Corneal Epithelial Disorders

NCT02104388

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 3
Phase 3 1

Therapeutic Areas

Dry Eye Syndrome 1
Dry Eye Disease 1
Corneal Epithelial Disorders 1

How the Senju Pharmaceutical Co. early-phase archive is shaped

5 indexed studies, none listed as recruiting (0% open); 4 completed (80%).

Phase mix: 1 late (III/IV) vs 4 early (I/II) (early-phase heavy).

Top condition: Dry Eye Syndrome (1 trial), 2 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Senju Pharmaceutical Co.: archived-pipeline peers nationwide

Peers matched on 5 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Senju Pharmaceutical Co. sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%5%10%15%20%25% Total trials Recruiting share Senju Pharmaceutical Co.4YouandMeAbbott Rapid DxAccess Business GroupAcera Surgical10xBio22nd Century Group23andMe3-C Institute for Social Development
Senju Pharmaceutical Co. sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Senju Pharmaceutical Co. sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 5 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Senju Pharmaceutical Co. page

5 registered trials is a research-attention snapshot, not an endorsement of Senju Pharmaceutical Co. or any single study.

  • None of Senju Pharmaceutical Co.'s trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Dry Eye Syndrome is the condition Senju Pharmaceutical Co. studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Dry Eye Syndrome trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Senju Pharmaceutical Co. pipeline card: 5 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.